Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian markets gain momentum
Thu, 30 Oct 11:30 am

After opening flat, the Indian Indices are witnessing broad based buying interest during the morning trading session. Software and consumer durables stocks are leading the gainers; while auto stocks are trading lower.

The BSE-Sensex is trading up 119 points. The NSE-Nifty is trading up 34 points. The BSE Mid Cap index is trading up 0.2% and the BSE Small Cap index is trading up 0.3%%. The rupee is trading at 61.45 to the US dollar.

Telecom stocks are trading mixed today. While Reliance Communications is leading the gainers; Mahanagar Telephone Nigam Ltd (MTNL) is leading the losers. India's largest telecom firm Bharti Airtel, will declare its 2QFY15 results today. The July-September quarter is seasonally weak for telecom firms. However, its rival Idea Cellular had posted strong results for the quarter. In other news regarding the company's DTH business, Bharti has announced a tie-up with Samsung to integrate a digital satellite tuner into Samsung's TVs. These integrated digital TVs (iDTV) will enable users to receive DTH signals directly without an external set top box. Samsung is expected to launch these TVs soon in the Indian market. DTH revenues constitute about 12.5% of the company's non mobile services revenues from India. Bharti Airtel was trading down 0.4% at the time of writing.

Most of the Indian pharma stocks are trading firm with Natco pharma and Orchid chemicals being the leading gainers in the pack. Dr Reddy's Laboratories has declared results for September quarter 2014. The company has reported topline growth by 7% YoY during the quarter, led by growth in India and RoW markets. The US formulations grew by just 7% YoY during the quarter. The operating margins declined by 2.4% to 22.7% during the quarter. Consequently, the operating profits were down by 3.5% YoY. Due to the poor performance at the operating level and higher taxes; the net profits declined by 16.8% YoY for the quarter. The stock was trading up by 1% at the time of writing.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets gain momentum". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.